XML 54 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock Option Activities of Long-Term Incentive and Option Plans The following information relates to our long-term incentive plans:

 

 

 

December 31, 2018

 

 

 

2016 Plan

 

 

2008 Plan

 

Maximum number of securities for issuance

 

 

2,750,000

 

 

 

 

 

Number of awards available to be granted (1)

 

 

1,825,150

 

 

 

 

 

Number of unvested restricted stock/restricted

   stock units outstanding

 

 

597,533

 

 

 

210,266

 

Number of options outstanding

 

 

 

 

 

124,000

 

Number of options exercisable

 

 

 

 

 

100,620

 

 

 

(1)

Includes 2008 Plan shares canceled, forfeited, expired unexercised, which became available for reissuance under the 2016 Plan after the effective date of the 2016 Plan.

 

 

 

2018

 

 

 

Shares

 

 

Weighted-Average

Exercise Price

 

Outstanding at beginning of year

 

 

206,210

 

 

$

30.34

 

Granted

 

 

 

 

$

 

Exercised

 

 

(2,525

)

 

$

7.86

 

Forfeited or expired

 

 

(79,685

)

 

$

25.59

 

Outstanding at end of year

 

 

124,000

 

 

$

33.86

 

Exercisable at end of year

 

 

100,620

 

 

$

33.97

 

 

 

 

2018

 

 

2017

 

 

2016

 

Total intrinsic value of options exercised during the year

 

$

 

 

$

 

 

$

216,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total fair value of options vested during the year

 

$

169,000

 

 

$

451,000

 

 

$

469,000

 

 

Summary of Restricted Stock Activity

A summary of restricted stock activity during 2018 is presented below:

 

 

 

Restricted Stocks

 

 

Restricted Stock Units

 

 

 

Shares

 

 

Weighted-Average

Grant Date Fair Value

 

 

Shares

 

 

Weighted-Average

Grant Date Fair Value

 

Unvested restricted stock outstanding at beginning of year

 

 

1,189,473

 

 

$

7.51

 

 

 

43,764

 

 

$

11.42

 

Granted

 

 

369,350

 

 

$

5.47

 

 

 

35,511

 

 

$

5.28

 

Vested

 

 

(806,927

)

 

$

9.11

 

 

 

(10,941

)

 

$

11.42

 

Cancelled or forfeited

 

 

(12,431

)

 

$

6.20

 

 

 

 

 

$

 

Unvested restricted stock outstanding at end of year

 

 

739,465

 

 

$

7.79

 

 

 

68,334

 

 

$

8.23

 

 

 

 

Restricted Stock

 

 

 

2018

 

 

2017

 

 

2016

 

Shares of restricted stock granted

 

 

369,350

 

 

 

469,465

 

 

 

850,771

 

Total fair value of restricted stock granted

 

$

2,019,000

 

 

$

4,277,000

 

 

$

6,652,000

 

Weighted-average fair value per restricted stock granted during year

 

$

5.47

 

 

$

9.11

 

 

$

7.82

 

Stock-based compensation expense - Cost of sales

 

$

385,000

 

 

$

312,000

 

 

$

240,000

 

Stock-based compensation expense - SG&A (1)

 

$

7,574,000

 

 

$

3,987,000

 

 

$

2,773,000

 

Income tax benefit

 

$

(398,000

)

 

$

(1,659,000

)

 

$

(1,157,000

)

Total weighted-average remaining vesting period in years

 

 

1.78

 

 

 

1.95

 

 

 

2.41

 

Total fair value of restricted stock vested during the year

 

$

7,355,000

 

 

$

3,124,000

 

 

$

2,579,000

 

 

 

(1)

See Note 15-Related Party Transactions.

 

 

 

Restricted Stock Units

 

 

 

2018

 

 

2017

 

 

2016

 

Shares of restricted stock units granted

 

 

35,511

 

 

 

37,992

 

 

 

27,654

 

Total fair value of restricted stock unit granted

 

$

187,000

 

 

$

375,000

 

 

$

375,000

 

Weighted-average fair value per restricted stock unit granted during

   year

 

$

5.28

 

 

$

9.87

 

 

$

13.56

 

Stock-based compensation expense - SG&A

 

$

187,000

 

 

$

375,000

 

 

$

375,000

 

Income tax benefit

 

$

(34,000

)

 

$

(115,000

)

 

$

(144,000

)

Total weighted-average remaining vesting period in years

 

 

1.75

 

 

 

3.05

 

 

 

2.50

 

Total fair value of restricted stock vested during the year

 

$

125,000

 

 

$

250,000

 

 

$

 

Valuation Assumptions of Granted Stock Options

The following table summarizes information about these granted stock options:

 

 

 

2018

 

 

2017

 

 

2016

 

Total weighted-average remaining vesting period in years

 

 

1.05

 

 

 

1.53

 

 

 

2.25

 

Stock-based compensation expense - Cost of Sales

 

$

141,000

 

 

$

317,000

 

 

$

321,000

 

Stock-based compensation expense - SG&A

 

$

71,000

 

 

$

108,000

 

 

$

836,000

 

Income tax benefit

 

$

(54,000

)

 

$

(164,000

)

 

$

(444,000

)

Stock Options Outstanding and Exercisable

 

 

 

 

 

 

 

 

 

Stock Options Outstanding At December 31, 2018

 

Exercise Prices

 

 

Shares

Outstanding

 

 

Weighted-

Average

Remaining

Contractual Life

in Years

 

 

Weighted-

Average Exercise

Price

 

 

Intrinsic Value of

Shares

Outstanding

 

$ 33.36

 

 

 

70,000

 

 

 

3.34

 

 

$

18.83

 

 

 

 

$ 34.50

 

 

 

54,000

 

 

 

1.27

 

 

$

15.02

 

 

 

 

$

33.36

 

-

$

34.50

 

 

 

124,000

 

 

 

4.61

 

 

$

33.85

 

 

$

 

 

 

 

 

 

 

 

 

 

Stock Options Exercisable At December 31, 2018

 

Exercise Prices

 

 

Shares

Outstanding

 

 

Weighted-

Average

Remaining

Contractual

Life in Years

 

 

Weighted-

Average

Exercise Price

 

 

Intrinsic Value of

Shares

Outstanding

 

$ 33.36

 

 

 

46,620

 

 

 

2.74

 

 

$

15.46

 

 

 

 

$ 34.50

 

 

 

54,000

 

 

 

1.57

 

 

$

18.52

 

 

 

 

$

33.36

 

-

$

34.50

 

 

 

100,620

 

 

 

4.31

 

 

$

33.98

 

 

$